News

Fierce Healthcare1d
New Evernorth program to cap out-of-pocket costs for Wegovy, Zepbound at $200
Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 ...
Cigna takes different approach with GLP-1s, more favorable for Eli Lilly
Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss medications at $200 per month, in a move analysts say is more favorable for Eli Lilly ...
Modern Healthcare1d
Cigna debuts GLP-1 copay cap
Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...
Managed Healthcare Executive5h
Evernorth to Cap Out-of-Pocket Cost for Wegovy and Zepbound at $200
Health plan sponsors are also expected to see a reduction in the net cost per prescription of GLP-1 medications to treat obesity.
Endpoints News3h
Cigna, No­vo of­fer low­er GLP-1 prices to lure pa­tients to brand-name drugs
Cigna on Wednesday said it negotiated with Novo Nordisk and Eli Lilly to secure deeper GLP-1 drug discounts for employers ...
Cigna Announces Copay Deal
Only half of health insurer Cigna’s (NYSE:CI) clients currently cover the popular GLP-1 weight loss drugs Wegovy and Zepbound because of their high costs. But the company’s pharmacy benefits unit ...
Explore more
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...